12 research outputs found
The Ethnomedicine of the Haya people of Bugabo ward, Kagera Region, north western Tanzania
\ud
The Kagera region, in north western Tanzania, is endowed with a strong culture of traditional medicine that is well supported by a rich diversity of medicinal plants. However, most of the plants in this region have not been documented nor evaluated for safety and efficacy. As an initiative in that direction, this study documented the knowledge on medicinal plant use by traditional healers of Bugabo Ward in Bukoba District. Key informants were selected with the help of local government officials and information on their knowledge and use of plants for therapeutic purposes was gathered using a semi-structured interview format. In this study 94 plant species representing 84 genera and 43 families were found to be commonly used in the treatment of a variety of human ailments. The family Asteraceae had the highest number of species being used as traditional medicines. The study revealed that Malaria is treated using the highest number of different medicinal species (30), followed by skin conditions (19), maternal illnesses and sexually transmitted diseases (14), respiratory diseases (11) and yellow fever, Herpes simplex and peptic ulcers (10). Majority of the species are used to treat less than five different diseases/conditions each and leaves were the most commonly used part, comprising 40% of all the reports on use of plant parts. Trees comprised the most dominant growth form among all plants used for medicinal purposes in the study area. Bugabo Ward has a rich repository of medicinal plants and this reinforces the need for an extensive and comprehensive documentation of medicinal plants in the area and a concomitant evaluation of their biological activity as a basis for developing future medicines.\u
Analysis of additivity and synergism in the anti-plasmodial effect of purified compounds from plant extracts
In the search for antimalarials from ethnobotanical origin, plant extracts are chemically fractionated and biological tests guide the isolation of pure active compounds. To establish the responsibility of isolated active compound(s) to the whole antiplasmodial activity of a crude extract, the literature in this field was scanned and results were analysed quantitatively to find the contribution of the pure compound to the activity of the whole extract. It was found that, generally, the activity of isolated molecules could not account on their own for the activity of the crude extract. It is suggested that future research should take into account the âdrugs beside the drugâ, looking for those products (otherwise discarded along the fractionation process) able to boost the activity of isolated active compounds
Best Practices on Chondroitin Quality in a Globalized Supply Chain: Quality Regimes, Standards, and Methodologies
There is modest clinical evidence supporting the safe use of Chondroitin Sulfate (CS) for pain management in arthritis patients.(Singh et al., 2015) In the United States CS is used as a dietary ingredient in dietary supplements intended to support joint health, while in the European Union countries CS is included in treatment regimens for osteoarthritis pain management. Accordingly the United States Pharmacopeia has set CS quality standard for dietary supplement grade CS, while the European Pharmacopoeia\u2019s quality standard are for pharmaceutical grade chondroitin sulfate. It has been reported that specific activity of CS depends on the quality: such as chondroitin sulfate structure and properties that determine its bioavailability and efficacy.(Volpi, 2009) Thus CS quality affects therapeutic utility of commercial preparations, particularly products manufactured to meet pharmaceutical standards versus products manufactured to meet food grade standards (dietary supplements). In this poster we discuss various testing methods available that can be used to establish identity, purity, strength, composition and limit of contaminants of CS. To ensure high quality and purity of CS material, we recommend the use of compendial CS standards with complementary analytical procedures as well as adherence to proper quality systems, good laboratory practices and training. These practices will ensure that only high quality CS is used in medicines and dietary supplements so that patients and consumers can benefit appropriately
Phytochemical and antitrypanosomal investigation of the fractions and compounds isolated from Artemesia elegantissima
Trypanosoma brucei brucei (T.b. brucei) infection causes death in cattle, while the current treatments have serious toxicity problems. However, natural products can be used to overcome the problems associated with parasitic diseases including T.b. brucei. Objective: Artemisia elegantissima Pamp (Asteraceae) was evaluated phytochemically for its constituents and antitrypanosomal potential against T.b. brucei for the first time. Scopoletin isolated from A. elegantissima has shown better potential then the standard drug suramin, used against T.b. brucei. Materials and methods: The ethanol extract of the aerial parts of A. elegantissima was fractionated by column and preparative thin-layer chromatography into six fractions (A-F) yielding 13 compounds, these were evaluated for their antitrypanosomal activity against T.b. brucei at different concentrations. Results: Thirteen compounds were isolated from A. elegantissima: (Z)-p-hydroxy cinnamic acid, stigmasterol, ÎČ-sitosterol, betulinic acid, bis-dracunculin, dracunculin, scopoletin, apigenin, dihydroluteolin, scoparol, nepetin, bonanzin, and 3',4'-dihydroxy bonanzin. The fractions D-F were found to be active at the concentration of 20â”g/ml and three compounds isolated from these fractions, scopoletin (MICââ€0.19â”g/ml), 3',4'-dihydroxy bonanzin (MICâ=â6.25â”g/ml) and bonanzin (MICâ=â20â”g/ml), were found to be highly active. Discussion and conclusion: Artemisia elegantissima was phytochemically and biologically explored for its antitrypanosomal potential against T.b. brucei. The number and orientation of phenolic hydroxyl groups play an important role in the antitrypanosomal potential of coumarins and flavonoids. The compounds 3',4'-dihydroxy bonanzin and scopoletin with low MIC values, hold potential for use as antitrypanosomal drug leads
In vitro antiplasmodial activity and toxicity assessment of plant extracts used in traditional malaria therapy in the Lake Victoria Region
As part of our program screening the flora of the Lake Victoria Region, a total of 54 organic extracts from seven plant families (8 species) were individually tested for antiplasmodial activity against chloroquine-sensitive [Sierra Leone (D-6)] and chloroquine-resistant [Vietnam (W-2)] strains. Only 22% of these extracts exhibited very high in vitro antiplasmodial activity. Six methanol (MeOH) extracts and one chloroform extract showed in vitro antiplasmodial activity against the D-6 Plasmodium falciparum strain, while only three MeOH extracts were active against the W-2 strain. All of the ethyl acetate extracts proved to be inactive against both strains of P. falciparum. A brine shrimp cytotoxicity assay was used to predict the potential toxicity of the extracts. The cytotoxicity to antiplasmodial ratios for the MeOH extracts were found to be greater than 100, which could indicate that the extracts are of low toxicity